Effective impairment of myeloma cells and their progenitors by hyperthermia

• Miki, Hirokazu

• Nakamura, Shingen

• Oda, Asuka

• Tenshin, Hirofumi

• Teramachi, Jumpei

• Hiasa, Masahiro

• Bat-Erdene, Ariunzaya

• Maeda, Yusaku

• Oura, Masahiro

• Takahashi, Mamiko

• Iwasa, Masami

• Harada, Takeshi

• Fujii, Shiro

• Kurahashi, Kiyoe

• Yoshida, Sumiko

• Kagawa, Kumiko

• Endo, Itsuro

• Aihara, Kenichi

• Ikuo, Mariko

• Itoh, Kohji

• Hayashi, Koichiro

• Nakamura, Michihiro

• Abe, Masahiro

Abstract

Multiple myeloma (MM) remains incurable, and MM-initiating cells or MM progenitors are considered to contribute to disease relapse through their drug-resistant nature. In order to improve the therapeutic efficacy for MM, we recently developed novel superparamagnetic nanoparticles which selectively accumulate in MM tumors and extirpate them by heat generated with magnetic resonance. We here aimed to clarify the therapeutic effects on MM cells and their progenitors by hyperthermia. Heat treatment at 43°C time-dependently induced MM cell death. The treatment upregulated endoplasmic reticulum (ER) stress mediators, ATF4 and CHOP, while reducing the protein levels of Pim-2, IRF4, c-Myc and Mcl-1. Combination with the proteasome inhibitor bortezomib further enhanced ER stress to potentiate MM cell death. The Pim inhibitor SMI-16a also enhanced the reduction of the Pim-2-driven survival factors, IRF4 and c-Myc, in combination with the heat treatment. The heat treatment almost completely eradicated “side population” fractions in RPMI8226 and KMS-11 cells and suppressed their clonogenic capacity as determined by in vitro colony formation and tumorigenic capacity in SCID mice. These results collectively demonstrated that hyperthermia is able to impair clonogenic drug-resistant fractions of MM cells and enhance their susceptibility to chemotherapeutic drugs.

Journal

• Oncotarget

  Oncotarget 9 (12), 10307-10316, 2017-12-07

  Impact Journals, LLC

Keywords

• hyperthermia
• plasmacytoma
• side population
• bortezomib
• Pim-2

Details

• CRID: 1050564287969173376
• NII Article ID: 120006576960
• ISSN: 19492553
• DOI: 10.18632/oncotarget.23121
• Web Site: http://repo.lib.tokushima-u.ac.jp/113059
• Web Site: https://www.oncotarget.com/lookup/doi/10.18632/oncotarget.23121
• Text Lang: en
• Article Type: journal article
• Data Source:
  • IRDB
  • Crossref
  • CiNii Articles
  • KAKEN